Investors

Profile

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other conditions. Ten registration studies are currently advancing related to eight Array-owned or partnered drugs: encorafenib (LGX818), binimetinib (MEK162), ARRY-797, selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Seattle Genetics).

Array BioPharma
Fact Sheet

Fact Sheet

Array BioPharma 2017 Annual Report

alt

Array BioPharma
Investor Presentation

Investor

Stock Quote & Chart

Copyright Nasdaq. Minimum 15 minutes delayed.

ShareThis Copy and Paste